Literature DB >> 12637365

A novel, voltage-dependent nonselective cation current activated by insulin in guinea pig isolated ventricular myocytes.

Yin Hua Zhang1, Jules C Hancox.   

Abstract

Insulin regulates cardiac metabolism and function by targeting metabolic proteins or voltage-gated ion channels. This study provides evidence for a novel, voltage-dependent, nonselective cation channel (NSCC) in the heart. Under voltage clamp at 37 degrees C and with major known conductances blocked, insulin (1 nmol/L to 1 micromol/L) activated an outwardly rectifying current (Iinsulin) in guinea pig ventricular myocytes. Iinsulin could be carried by Cs+, K+, Li+, and Na+ ions but not by NMDG+. It was inhibited by the NSCC blockers gadolinium and SKF96365 but not flufenamic acid. Iinsulin was largely blocked by the insulin receptor tyrosine kinase inhibitor HNMPA-(AM)3 and by the phospholipase C inhibitor U73122 but not by its inactive analogue U73433. Staurosporine, a potent blocker of protein kinase C, did not prevent the activation of Iinsulin. Application of an analogue of diacylglycerol, 1-oleoyl-2-acetyl-sn-glycerol, mimicked the effect of insulin. This activated an outwardly rectifying NSCC that could be carried by Cs+, K+, Li+, or Na+ and that was blocked by gadolinium but not by flufenamic acid or staurosporine. We conclude that the intracellular pathway leading to activation of this novel cardiac NSCC involves phospholipase C, is protein kinase C-independent, and may depend on direct channel activation by diacylglycerol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637365     DOI: 10.1161/01.RES.0000065920.64121.FC

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Induction of a novel cation current in cardiac ventricular myocytes by flufenamic acid and related drugs.

Authors:  R Macianskiene; A Gwanyanya; K R Sipido; J Vereecke; K Mubagwa
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

2.  Whole-exome sequencing reveals microsatellite DNA markers for response to dofetilide initiation in patients with persistent atrial fibrillation: A pilot study.

Authors:  Nick Kinney; Timothy R Larsen; David M Kim; Robin T Varghese; Steven Poelzing; Harold R Garner; Soufian T AlMahameed
Journal:  Clin Cardiol       Date:  2018-06-11       Impact factor: 2.882

Review 3.  The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis.

Authors:  Kristin K Haga; Katie L McClymont; Scott Clarke; Rebecca S Grounds; Ka Ying B Ng; Daniel W Glyde; Robert J Loveless; Gordon H Carter; R Peter Alston
Journal:  J Cardiothorac Surg       Date:  2011-01-10       Impact factor: 1.637

4.  The role of acute hyperinsulinemia in the development of cardiac arrhythmias.

Authors:  László Drimba; Róbert Döbrönte; Csaba Hegedüs; Réka Sári; Yin Di; Joseph Németh; Zoltán Szilvássy; Barna Peitl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-10       Impact factor: 3.000

5.  Pharmacological evidences for the stimulation of calcium-sensing receptors by nifedipine in gingival fibroblasts.

Authors:  Toshimi Hattori; Toshiaki Ara; Yoshiaki Fujinami
Journal:  J Pharmacol Pharmacother       Date:  2011-01

6.  Perioperative glycemic control and its outcome in patients following open heart surgery.

Authors:  Khalid M Siddiqui; Muhammad A Asghar; Muhammad F Khan; Fazal H Khan
Journal:  Ann Card Anaesth       Date:  2019 Jul-Sep

7.  High glucose regulates the activity of cardiac sarcolemmal ATP-sensitive K+ channels via 1,3-bisphosphoglycerate: a novel link between cardiac membrane excitability and glucose metabolism.

Authors:  Sofija Jovanović; Aleksandar Jovanović
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

8.  Multiple ion channel block by the cation channel inhibitor SKF-96365 in myocytes from the rabbit atrioventricular node.

Authors:  Hongwei Cheng; Alexander E Curtis; Claire Fellingham; Jules C Hancox
Journal:  Physiol Rep       Date:  2016-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.